These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3796213

  • 1. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
    Pernow J, Lundberg JM, Kaijser L.
    Life Sci; 1987 Jan 05; 40(1):47-54. PubMed ID: 3796213
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
    Pernow J, Lundberg JM, Kaijser L.
    Clin Physiol; 1989 Feb 05; 9(1):67-75. PubMed ID: 2706916
    [Abstract] [Full Text] [Related]

  • 3. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
    Ahlborg G, Weitzberg E, Lundberg JM.
    Clin Physiol; 1992 Mar 05; 12(2):145-53. PubMed ID: 1582134
    [Abstract] [Full Text] [Related]

  • 4. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug 05; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Aug 05; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 7. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G.
    Circulation; 1991 Mar 05; 83(3):774-7. PubMed ID: 1999028
    [Abstract] [Full Text] [Related]

  • 8. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
    Ahlborg G, Weitzberg E, Sollevi A, Lundberg JM.
    Acta Physiol Scand; 1992 Jun 05; 145(2):139-49. PubMed ID: 1636443
    [Abstract] [Full Text] [Related]

  • 9. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P.
    Acta Anaesthesiol Scand; 1987 Feb 05; 31(2):132-8. PubMed ID: 3564869
    [Abstract] [Full Text] [Related]

  • 10. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J, Kahan T, Hjemdahl P, Lundberg JM.
    Acta Physiol Scand; 1988 Jan 05; 132(1):43-50. PubMed ID: 2906210
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 Jan 05; 147(1):15-25. PubMed ID: 8095766
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B.
    Regul Pept; 1985 Dec 05; 13(1):41-52. PubMed ID: 3841402
    [Abstract] [Full Text] [Related]

  • 13. Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.
    Rudehill A, Olcén M, Sollevi A, Hamberger B, Lundberg JM.
    Acta Physiol Scand; 1987 Dec 05; 131(4):517-23. PubMed ID: 3442241
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE, Lundberg JM.
    Acta Physiol Scand; 1997 Nov 05; 161(3):327-38. PubMed ID: 9401585
    [Abstract] [Full Text] [Related]

  • 15. Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.
    Juul R, Edvinsson L, Fredriksen TA, Ekman R, Brubakk AO, Gisvold SE.
    Acta Neurochir (Wien); 1990 Nov 05; 107(3-4):75-81. PubMed ID: 2077856
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity.
    Tepperman BL, Whittle BJ.
    Br J Pharmacol; 1991 Jan 05; 102(1):95-100. PubMed ID: 2043936
    [Abstract] [Full Text] [Related]

  • 17. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM, Rudehill A, Sollevi A, Hamberger B.
    Br J Pharmacol; 1989 Mar 05; 96(3):675-87. PubMed ID: 2566349
    [Abstract] [Full Text] [Related]

  • 18. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y, Satoh M, Aizawa M, Funazaki T, Niwano S, Miyajima S, Shibata A.
    Jpn Heart J; 1987 Nov 05; 28(6):891-8. PubMed ID: 2832630
    [Abstract] [Full Text] [Related]

  • 19. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B, Lindvall K, Lundberg JM, Sigurdsson A, Swedberg K.
    Clin Physiol; 1994 Mar 05; 14(2):123-34. PubMed ID: 8205743
    [Abstract] [Full Text] [Related]

  • 20. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE, Lundberg JN, Weitzberg E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 05; 365(2):106-11. PubMed ID: 11819028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.